Pteridinone derivatives for use as stearoyl CoA desaturase inhibitors
US7662819B2 · kind B2 · utility
5Cited by
6References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 5, 2007 |
| Grant date | Feb 16, 2010 |
| Priority date | — |
| Expiry date | Oct 5, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses pteridinone derivatives for use as inhibitors of stearoyl-CoA desaturase having the structure of Formula I:The compounds are useful in treating and/or preventing various human diseases, mediated by stearoyl-CoA desaturase (SCD) enzymes, especially diseases related to abnormal lipid levels, cardiovascular disease, diabetes, obesity, metabolic syndrome and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.